ReviewCurrent hematologic malignancy reports2026

Molecular Pathogenesis and Targeted Therapies for Myeloproliferative Hypereosinophilic Neoplasms.

Colette Hanna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.